Category: Sem categoria

On August 13, 2024, at Pier Mauá, Heptech made its mark at RIW 2024. The company showcased its latest advancements in enhanced heparins, presenting innovative projects that promise to revolutionize the treatment of thrombotic diseases. At the event, Heptech highlighted its research on new heparin formulations aimed at increasing efficacy and reducing side effects, contributing to safer and more effective medicine. Heptech’s participation in RIW 2024 not only reaffirmed its commitment to innovation but also emphasized the importance of partnerships with institutions like FAPERJ for advancing science and health.

See  the report on our participation in the event.

One of the project development strategies at Heptech is carried out through the acquisition of resources and knowledge from funding and acceleration sources. In the past, Heptech has received funding from FAPERJ and SENAI, and in 2022, participated in SEBRAE’s CATALISA ICT project, a program that helped advance the development of our products aimed at scaling up and market entry.

Heptech was chosen from a range of FAPERJ projects to create a explainer video showcasing its initiatives. In the video, Heptech discusses its innovations in the anticoagulant market, the significance of its discoveries for the industry, and the collaborations with UFRJ and funding sources (FAPERJ) that have made its development possible. To learn more about Heptech, watch the video:

Heptech was invited to showcase our innovative work at Rio Innovation Week (RIW) 2022. At this dynamic event, Heptech had the opportunity to network with other startups, as well as government and private sector entities, discussing innovation in Brazil and globally. You can access Heptech’s presentation here:

 

 

 

 

 

Ver essa foto no Instagram

 

 

 

 

 

 

 

 

 

 

 

Uma publicação compartilhada por faperjoficial (@faperjoficial)